Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 1 6Phase 2 3Phase 1/2 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Follicular 2Lipoma 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 900Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Deoxycholic Acid × Clear all
NCT00608842 2016-01-14

Phase 2 Study for the Treatment of Superficial Lipomas

Kythera Biopharmaceuticals

Phase 2 Completed
62 enrolled 12 charts

Lipoma

NCT00618618 2015-07-14

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Kythera Biopharmaceuticals

Phase 2 Completed
73 enrolled 22 charts
Lymphoid

Lymphoma, Follicular

NCT01032889 2015-06-15

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

Kythera Biopharmaceuticals

Phase 2 Completed
129 enrolled 17 charts
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡